Narrow Your Results

Strategy

Sections

Keywords

Places

Gray Ratings

Showing 1 - 3 of 3 Results for "Australia"

Results

CD4 counts
Antiretroviral therapy initiated at CD4 counts between 350 and 550 can result in fewer serious HIV-1-related clinical events or death.
Provision and Access
6 studies Gray II, IIIa, IIIb CD4 counts, HAART, treatment Australia, Botswana, Brazil, Canada, Côte d'Ivoire, Europe, India, Kenya, Malawi, North America, South Africa, Thailand, United States, Zimbabwe
Viral suppression with ARV therapy can minimize the risk of HIV transmission and improve health.
Staying Healthy and Reducing Transmission
12 studies Gray II, IIIa, IIIb CD4 counts, and Zimbabwe, condom use, prevention, seroconversion, serodiscordant, sex behavior, the United States of America, treatment, viral load Australia, Botswana, Brazil, China, Côte d'Ivoire, India, Italy, Kenya, Malawi, Rwanda, South Africa, Spain, Sub-Saharan Africa, Tanzania, Thailand, Uganda, United States, Zambia, Zimbabwe
Early initiation of antiretroviral therapy results in improved quality of life and reduced mortality.
Provision and Access
12 studies Gray I, II, IIIa, IIIb CD4 count, CD4 counts, Czech Republic, Mali, Morocco, TB, Thailand and Uganda, and Zimbabwe, mortality rates, preventive therapy, quality of life, treatment, tuberculosis Argentina, Australia, Botswana, Brazil, Chile, Côte d'Ivoire, Estonia, Europe, Haiti, India, Kenya, Lesotho, Malawi, Malaysia, Mexico, Nigeria, Peru, Poland, South Africa, Sub-Saharan Africa, Thailand, USA, Uganda